Biomedical Intelligence Supporting Precision Drug Development

Lucera helps biopharma teams determine where a therapeutic mechanism is most likely to translate into patient benefit – and what it takes to turn that insight into successful drug development.

Built on 15 years of biomedical expertise, Lucera connects mechanism of action with disease biology, patient and clinical evidence to provide a clear biological rationale and recommendation for the next development decision.

Get in touch Case studies

Scroll

Addressing the critical questions that drive successful drug development

Precision medicine made disease heterogeneity actionable, linking treatment to individual molecular makeup. Lucera applies this principle to drug development. We connect mechanistic biology, patient context, and clinical development evidence to inform the decisions that shape a drug development program.

Evidence in practice: select case studies

We are looking at a question from a variety of independent perspectives. With this orthogonal approach, Lucera examines the therapeutic mechanism, patient biology, and clinical context independently and then brings the evidence together for the fullest possible picture and plausibility.

When the evidence converges, confidence in the development hypothesis increases. When it diverges, the differences expose assumptions, evidence gaps or biological constraints that need to be resolved before moving a development program forward. The result is what we call precision drug development – giving you the exact information you need to make your next step with confidence.

Our People

Our founders have worked together across three generations of biomedical innovation, from LION Bioscience through Molecular Health to Lucera, progressively moving from organizing biological knowledge, to enabling precision medicine, to bringing the same rigor now to precision drug development.

Our team’s expertise spans biochemistry, molecular biology, bioinformatics, computational biology, AI, clinical and commercial development and beyond. This breadth of expertise and in-depth knowledge enable us to understand and contextualize the insights we deliver, giving clients a fully vetted recommendation with a clear course of action to enable precise drug development.

Building on a history of success

Lucera has a solid track record of enabling clients to make well-informed, evidence-based development and investment decisions.

Selection of clients and partners

News, events and publications

Decide with confidence

We have the team, the technology and the insight, providing the evidence you need to determine the best development path forward.

Contact Lucera